Alessandro Leonetti (@Ale_leonetti) profile picture

MD, PhD. Medical Oncologist at University Hospital of Parma, Italy.

Parma, Emilia Romagna
Joined December 2011
Photo by Alessandro Leonetti (@Ale_leonetti)Photo by Alessandro Leonetti (@Ale_leonetti)Photo by Alessandro Leonetti (@Ale_leonetti)Photo by Alessandro Leonetti (@Ale_leonetti)Photo by Alessandro Leonetti (@Ale_leonetti)Photo by Alessandro Leonetti (@Ale_leonetti)
Alessandro Leonetti retweeted
🔥ALNEO: Neoadjuvant alectinib in potentially resectable stage III ALK+ NSCLC 🆙 @JCO_ASCO @ASCO 🎯MPR 42% (primary endpoint met), pCR 12% 🎯ORR 67%; 85% underwent surgery, R0 in 86% 🎯mFU 26.8 mo: EFS/DFS/OS not reached 🎯Grade ≥3 AEs 9% (neoadjuvant) & 27% (adjuvant) 🎙 @Ale_leonetti #LCSM @OncoAlert @Larvol @ALKPositiveinc ascopubs.org/doi/abs/10.1200…
🔄 #ASCO25 REVIEW🔁 ☑️#LCSM Rapid Oral, LocReg/SCLC 🔥ALNEO: Alectinib as neoadjuvant treatment in potentially resectable stage III ALK-positive NSCLC 🎙️ Dr. Marcello Tiseo 🎯Surgery 85%, R0 86%, 🎯MPR 46% (15/33), pCR 12% (4/33) @OncoAlert @ASCO @Larvol meetings.asco.org/2025-asco-…
1
10
27
1,529
Corriamo per #oncorun2026! Noi oncologi dell’AOU di Parma sosteniamo il valore dell’attività fisica nella prevenzione e cura dei tumori, partecipando a #DonneInCorsa2026, per lo sport, l’equità di genere e la tutela dei diritti. #AIOM #NICSO
2
54
University Hospital of Parma at #WCLC2025 in Barcelona 🇪🇸 with 2 awards, 2 oral presentations and 6 posters! Proud of our thoracic multidisciplinary group led by Prof @MarcelloTiseo. Good job! 🫁🔬🏆 #LungCancer #Italianresearch
1
2
13
347
Honored to present the results of the LiBRA study at #WCLC25, focusing on patients with #BRAF V600E–mutant #NSCLC treated with dabrafenib + trametinib. An important step towards molecular monitoring in this rare NSCLC subset. #lungcancer #liquidbiopsy #GOIRC
1
5
20
823
🚨@OncoAlert Hot Off The Press Just presented @ASCO #ASCO25 Results of #ALNEO phase 2 trial of: #Neoadjuvant #Alectinib in potentially resectable stage Ill #ALK+ Non-Small Cell #LungCancer ✅pCR: 12% ✅MPR: 46% ✅ORR: 67% ✅Safety profile consistent with previous studies
2
20
44
3,566
Alessandro Leonetti retweeted
1
6
40
1,681
An honor to present the IA results of #ALNEO phII trial of #neoadjuvant #alectinib in potentially resectable stage III #ALK+ #NSCLC at @IASLC #WCLC2024: ➡️ 18 pts included in IA ✅ MPR 39%, pCR 17%, no relevant toxicity Final analysis on 33 pts awaited!
1
1
16
281
Happy to share our latest manuscript on liquid biopsy and 18F-FDG PET as noninvasive predictors of 1L #osimertinib outcome in #EGFR-mutated #NSCLC. Thanks to all the team! clinical-lung-cancer.com/art…
1
1
2
117
Alessandro Leonetti retweeted
Best post award for waning effect of adjuvant EGFR TKIs in resected NSCLC. Cochrane Metanalysis Lung Cancer Group. @CochraneLibrary @cochranecollab @MOcchipintiMD @MImbimbo1 @vittoriosimeon @giusvisc #ELCC24
1
10
1
55
3,132
Alessandro Leonetti retweeted
Wonderful educational section on Liquid Biopsy in clinical practice at the #ELCC24 with an outstanding panel of experts @UmbertoMalapel1 @CharuAggarwalMD Natasha Leighl and T. Mitsudomi @myESMO @IASLC – at Prague, Czech Republic
1
6
1
16
7,308
Great honor to present the results of LiBRA study on liquid biopsy in BRAF V600E-mutated NSCLC treated with 1L dabrafenib + trametinib! 🧪🫁#ELCC2024 #GOIRC #LiBRA
2
2
43
1,935
Our RW study of first-line pembrolizumab plus platinum-pemetrexed in Italian patients with advanced non-squamous lung cancer is out on Eur J Cancer! ➡️ 1068 pts ➡️ mOS 16.1m, mPFS 9.9m, ORR 43.4% ➡️ Favourable outcomes in PD-L1 < 1% 👉 ejcancer.com/article/S0959-8… Great teamwork!
2
5
20
629
Alessandro Leonetti retweeted
Intrinsic Resistance to #Osimertinib in EGFR Mutated #NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators link.springer.com/article/10…
1
3
127
Alessandro Leonetti retweeted
3
15
5
58
18,991
🚨🔥The future of #ThoracicOncology is in great hands! The 2023 @IASLC #Academy, for #EarlyCareer #Physicians & #Researchers, meeting at #WCLC23 in Singapore. Outstanding presentations by amazing members/mentees. Honored to serve as a faculty along with great colleagues @ChristianRolfo @LuisRaezMD @marinagarassino @AnneTsao2 @JPatelMD @acmoorephd @JackWestMD & others. #LCSM #LungCancer.
2
18
3
79
21,976
Alessandro Leonetti retweeted
What a fantastic event! Happy to be part of this group!
Starting the #WCLC23 🇸🇬with our IASLC Academy! Very excited to meet all the future leaders in thoracic oncology! @IASLC @RManochakian @marinagarassino @AnneTsao2 @LuisRaezMD @Piuchagarrido @JPatelMD @JackWestMD @karenkellymd @HwakeleeMD
2
8
790